Prenetics Taps DTC Veteran Hudson Leogrande to Board as IM8 Eyes TikTok, Meta Growth
Event summary
- Prenetics appoints Hudson Leogrande, CEO of Comfrt, to its board as independent director.
- IM8, Prenetics' health and longevity brand, crossed $100M ARR in 11 months and aims for $250M-$300M ARR by end of 2026.
- Leogrande brings expertise in scaling DTC brands via TikTok and Meta, where Comfrt is a top advertiser.
- Prenetics now has three independent directors on its four-member board.
- David Vanderveen resigned from the board concurrent with Leogrande’s appointment.
The big picture
Prenetics’ appointment of Hudson Leogrande underscores its push into social commerce, leveraging his expertise in scaling DTC brands through TikTok and Meta. The move comes as IM8 rapidly expands, highlighting the strategic importance of digital-first customer acquisition in the health and longevity sector. With three independent directors now on the board, Prenetics reinforces its commitment to governance as it navigates its next growth phase.
What we're watching
- Social Commerce Scaling
- How IM8 will deploy Comfrt’s TikTok and Meta playbook to accelerate its own growth.
- Revenue Trajectory
- Whether IM8 can sustain its rapid ARR growth and meet its $250M-$300M target by year-end.
- Governance Impact
- The effect of Leogrande’s appointment on Prenetics’ strategic direction and board dynamics.
Related topics